| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.9 |